23 December 2008
GlaxoSmithKline and Archemix form strategic alliance to develop aptamers to treat inflammatory diseases
Chris Viehbacher, former President, North American Pharmaceuticals, gave a presentation at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on 12 June in California.
We aim to create the best product pipeline in the industry for the benefit of patients, consumers and society.
Our R&D organisation measures productivity by the number and innovation of the products it creates, and also by the commercial value of the products.
Find out more about our pipeline